PlainRecalls
FDA Drug Critical Class I Terminated

HARD DAWN, Rise and Shine capsules, 500 mg, packaged in 10-count blisters per carton, Made in Malaysia, UPC 680044 364926, ASIN: B077XCCL59

Reported: February 16, 2022 Initiated: January 28, 2022 #D-0561-2022

Product Description

HARD DAWN, Rise and Shine capsules, 500 mg, packaged in 10-count blisters per carton, Made in Malaysia, UPC 680044 364926, ASIN: B077XCCL59

Reason for Recall

Marketed Without an Approved NDA/ANDA: Firm was informed by Amazon that analytical testing showed the presence of tadalafil. Tadalafil is a FDA approved drug, making this product an unapproved drug.

Details

Recalling Firm
Esupplementsales, LLC
Units Affected
500 cartons
Distribution
Nationwide in the USA via Amazon at www.amazon.com
Location
Reno, NV

Frequently Asked Questions

What product was recalled?
HARD DAWN, Rise and Shine capsules, 500 mg, packaged in 10-count blisters per carton, Made in Malaysia, UPC 680044 364926, ASIN: B077XCCL59. Recalled by Esupplementsales, LLC. Units affected: 500 cartons.
Why was this product recalled?
Marketed Without an Approved NDA/ANDA: Firm was informed by Amazon that analytical testing showed the presence of tadalafil. Tadalafil is a FDA approved drug, making this product an unapproved drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 16, 2022. Severity: Critical. Recall number: D-0561-2022.